The MS Podcast
A promising biomarker in MS: Neurofilament light chain
Avsnitt

A promising biomarker in MS: Neurofilament light chain

Biomarkers are important in MS, as they can potentially help with diagnosing patients, inform about disease prognosis, and help monitor disease activity and progression. Neurofilament light chain (NfL) is one of the most promising biomarkers in MS, but is it ready for clinical practice? In this episode, Professor of Neurology Finn Sellebjerg will tell us about the potential and limitations of this exciting biomarker. GZNO.MS.19.11.0310

Podden och tillhörande omslagsbild på den här sidan tillhör Sanofi Genzyme. Innehållet i podden är skapat av Sanofi Genzyme och inte av, eller tillsammans med, Poddtoppen.